Patients who have preexisting respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD) and live in areas with…
Home »
FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…
Study examines antibody response to COVID-19 vaccination in patients with kidney failure
In a recent study, most patients with kidney failure who were undergoing hemodialysis developed a substantial antibody response following the…
Patients should receive COVID-19 vaccine before surgery to reduce risk of death
Patients waiting for elective surgery should get COVID-19 vaccines ahead of the general population—potentially helping to avoid thousands of post-operative…
Research in metaphors enables better understanding of depression and patients’ needs
“You have to win the battle against depression,” “what counts is not surrendering” and “this is not a short road”…
Another study finds COVID patients face higher risk for stroke
(HealthDay)—A new study adds to mounting evidence that COVID patients have an added risk of stroke. Researchers analyzed data on…
One in three older thyroid patients take medications that interfere with thyroid function tests
Nearly one-third of adults age 65 and older who take thyroid hormone also take medications that are known to interfere…
Long-term stroke death rates are higher among Black Medicare patients
A long-term look at Medicare patients shows that Black patients who have an ischemic stroke (blocked blood flow to the…
Albumin provides no benefit to hospitalized patients with advanced liver disease
Daily infusions of albumin provide no significant health benefit to patients hospitalised with advanced liver disease, over and above ‘standard…
FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.…